RFC2 and astrocytoma (excluding glioblastoma): Moreover, RFC2 expression was obviously increased in LGG samples with WHO III grade (P < 0.001), astrocytoma (P = 0.041 and P = 0.023), and IDH1 wild-type (P < 0.001) (Fig. 11E–G).